AerBetic
AerBetic is a Birmingham, Alabama-based startup developing a non-invasive wearable bracelet/pendant that uses MEMS-based nano gas sensors to detect volatile organic compounds in exhaled breath, alerting Type 1 diabetic patients and their caregivers to hypoglycemic and hyperglycemic episodes via a companion iOS app.
- Company typePrivate
- Founded2018
- HeadquartersBirmingham, United States
- Headcount1–10
- GTM typeB2C
- OfferingHardware or Manufacturing
What AerBetic does
AerBetic, Inc. is a Birmingham, Alabama-based, founder-led startup founded in 2018 by Arnar Thors that is developing a non-invasive, wearable diabetes alert system designed to detect hypoglycemic and hyperglycemic episodes without finger sticks or subcutaneous sensors. The core product consists of a wearable device (bracelet or pendant form factor) that integrates MEMS-based nano gas sensors — sourced through a core partnership with AerNos — to analyze volatile organic compounds in exhaled breath at parts-per-billion concentrations, paired with a companion iOS mobile app that displays status, pushes alerts, and enables 24/7 caregiver monitoring. The product also runs a continuous-learning personalization loop in which patients input actual glucose readings so the system can refine its detection to each user's unique breath signature over time.
The company monetizes through hardware sales of the wearable device and a presumed subscription/freemium model around the mobile app, with pricing positioned below incumbent continuous glucose monitoring solutions; a 6–8 month beta tester program with lifetime discounts serves as the conversion mechanism. Distribution is direct-to-consumer via its own website, with no app store listing captured and Android explicitly deferred. The customer base is split between Type 1 diabetic patients (primary segment) and their caregivers — especially parents of diabetic children — with no enterprise or institutional contracts disclosed.
AerBetic is pre-commercial as of the most recent available evidence: the website labels the product "Coming Soon," headcount sits at 1–10, on-record capital consists of a 2019 ~$100K raise and the Southern Research i6 Challenge Grant plus the Alabama LaunchPad prize. Its go-to-market has leaned heavily on earned media (Wired, CNBC, Fox, CBS, ABC, Chicago Tribune, Smithsonian Magazine), CES exhibitions (CES 2019 and CES 2020 Innovation Award Honoree in Health and Wellness), and social/community channels rather than paid acquisition or institutional sales.
AerBetic firmographics
Firmographics- Name
- AerBetic
- Legal name
- AerBetic, Inc.
- Website
- https://aerbetic.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- AerBetic is a Birmingham, Alabama-based startup developing a non-invasive wearable bracelet/pendant that uses MEMS-based nano gas sensors to detect volatile organic compounds in exhaled breath, alerting Type 1 diabetic patients and their caregivers to hypoglycemic and hyperglycemic episodes via a companion iOS app.
- Ownership category
- akta.pro rank
AerBetic industry classification
Industry- Product category
- Non-invasive Diabetes Monitoring Wearables
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Other Measuring and Controlling Device Manufacturing (334519)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Industrial Instruments For Measurement, Display, And Control (3823)
- akta.pro primary industry
- Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers) (CRACAQAE)
- akta.pro secondary industry
- Blood Glucose Monitoring (BGM) Meters & Test Strips (HLAHAHAG)
Keywords
Where AerBetic is headquartered
LocationHeadquarters
- HQ city
- Birmingham
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
AerBetic business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- Wearable Device Sales: Sale of wearable hardware devices (bracelets and pendants) containing the nano-gas sensor technology. The company mentions the system will cost less than most glucose monitoring solutions.
- Mobile App Services: Companion smartphone app (iOS only at launch) that displays current and recent data, provides alerts, and enables caregiver monitoring. Likely operates on subscription or freemium model with premium features.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Wearable device with app - Coming Soon |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
AerBetic product offering
Product offeringCore offering
AerBetic develops and sells non-invasive wearable diabetes alert devices that use proprietary MEMS-based nano-gas sensors to detect volatile organic compound (VOC) signatures associated with hyperglycemia and hypoglycemia in a user's exhaled breath. The hardware is paired with a companion mobile application that delivers alerts, tracks readings, and connects users to caregivers, providing an alternative to finger-stick blood glucose monitoring.
Product overview
AerBetic offers a non-invasive wearable diabetes monitoring system consisting of two main components: (1) the AerBetic Wearable Device, available as a bracelet or pendant, which uses nano-gas sensors to detect volatile organic compounds in exhaled breath indicative of hypoglycemic and hyperglycemic episodes, and (2) the AerBetic Mobile App (iOS), which receives alerts from the device, displays status data, and enables caregivers to monitor patients 24/7. The system employs machine learning to personalize detection to each user's unique breath signature over time.
Differentiator
Problem solved
Functional benefit
Products and services
- AerBetic Wearable Device
- AerBetic Mobile App
Quantifiable outcome
- Non-invasive glucose monitoring eliminates need for finger sticks and continuous blood glucose monitoring devices
- +1 more outcomes
Companies that use AerBetic
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
AerBetic technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature5 records
AerBetic partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- AerNoscoreAerNos (San Diego-based company) provides MEMS-based nano gas sensors used in AerBetic devices. The sensors analyze exhaled breath to detect potentially dangerous blood glucose levels. AerBetic exhibited in the AerNos booth at CES events. This is a critical technology partnership for the core sensor functionality.
- University of Alabama at Birmingham (Kristen Noles, DNP, RN, CNL)minorKristen Noles, a Nurse Leader at UAB, provided endorsement and clinical perspective on AerBetic's technology. She noted that Type 1 Diabetics and caregivers have been seeking non-invasive monitoring solutions. Her clinical endorsement validates the product's potential impact.
- Southern ResearchminorSouthern Research awarded AerBetic a research grant (i6 Challenge Grant) to support development of the non-invasive diabetes monitoring technology. This is a grant/funding relationship rather than a commercial partnership.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
AerBetic competitors and assessment
Company assessmentDirect peers
- Dexcom: Market leader in continuous glucose monitoring (CGM) hardware (G6, G7). Most directly comparable competitor as both companies offer wearable glucose-monitoring devices for diabetic patients, with Dexcom's invasive subcutaneous sensor setting the accuracy bar AerBetic's non-invasive approach must clear.
- Know Labs: Public company developing a non-invasive glucose monitor (UBand) using radiofrequency spectroscopy in a wrist-worn form factor. Closely comparable as a non-invasive, wearable consumer glucose monitor competing for the same end users.
- Medtronic Diabetes: Offers the Guardian Connect CGM and integrated insulin pump systems. Comparable as an incumbent in wearable diabetes monitoring with deep clinical and payer relationships that any new entrant must navigate.
- Abbott Diabetes Care (FreeStyle Libre): Sells the FreeStyle Libre family of CGM sensors, the highest-volume CGM platform globally. Directly comparable as a wearable glucose monitor for diabetic patients, with an installed-base and cost advantage AerBetic will need to undercut or differentiate against.
- Alertgy: Startup developing a non-invasive, wrist-worn continuous glucose monitor using dielectric spectroscopy. Comparable in approach (non-invasive wearable) and in targeting the same Type 1 / Type 2 diabetic consumer segment.
- Nemaura Medical: Developer of sugarBEAT, a non-invasive, wearable adhesive CGM patch using skin-patch sensors. The most directly comparable company in approach (non-invasive, wearable) and stage (pre-commercial / early commercial) to AerBetic.
- Senseonics (Eversense): Maker of Eversense, an implantable long-term CGM (up to 180 days). Comparable as a glucose-monitoring company pursuing an alternative form factor to incumbent finger-stick and short-term CGM approaches.
Emerging players
- DiaMonTech: Berlin-based developer of non-invasive glucose monitoring using infrared spectroscopy. Comparable as a non-invasive glucose technology developer, though its form factor (desktop/handheld) differs from AerBetic's wearable.
- LifePlus: Developer of a non-invasive, multi-parameter wearable health monitor (including glucose trending) using spectroscopy. Comparable as an emerging non-invasive wearable health device company targeting similar chronic-disease consumers.
Broad incumbents
- Roche Diabetes Care: Major incumbent in blood glucose monitoring (Accu-Chek) with deep pharmacy and payer distribution. Comparable as a broad glucose-monitoring incumbent that AerBetic would need to displace in retail channels.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
AerBetic social profiles
Digital presenceAerBetic financial estimates
Financial estimateRevenue estimate
Valuation estimate
AerBetic leadership team
Management profileNumber of profiles
Profiles3 records
AerBetic funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AerBetic M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AerBetic
What does AerBetic do?
AerBetic develops and sells non-invasive wearable diabetes alert devices that use proprietary MEMS-based nano-gas sensors to detect volatile organic compound (VOC) signatures associated with hyperglycemia and hypoglycemia in a user's exhaled breath. The hardware is paired with a companion mobile application that delivers alerts, tracks readings, and connects users to caregivers, providing an alternative to finger-stick blood glucose monitoring.
Is AerBetic a public or private company?
AerBetic is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was AerBetic founded?
AerBetic was founded in 2018. It employs 1 to 10 people.
Where is AerBetic based?
AerBetic is headquartered in Birmingham, United States, in the North America region.
How does AerBetic make money?
Two revenue lines are on record. Wearable Device Sales are the primary driver. The others are mobile App Services.
Who are AerBetic's main competitors?
Direct peers on record are Dexcom, Know Labs, Medtronic Diabetes, Abbott Diabetes Care (FreeStyle Libre), Alertgy, Nemaura Medical and Senseonics (Eversense). Emerging players are DiaMonTech and LifePlus. Roche Diabetes Care is listed as a broad incumbent.
Does AerBetic have an API?
No public API is recorded for AerBetic.
What industry is AerBetic in?
AerBetic's product category is Non-invasive Diabetes Monitoring Wearables. Its primary akta.pro industry code is CRACAQAE, Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers), with a secondary code of HLAHAHAG, Blood Glucose Monitoring (BGM) Meters & Test Strips. Its NAICS code is 334510 and its SIC code is 3845.